POLIANI, Pietro Luigi
 Distribuzione geografica
Continente #
NA - Nord America 8.697
EU - Europa 2.897
AS - Asia 1.797
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
Totale 13.426
Nazione #
US - Stati Uniti d'America 8.672
CN - Cina 1.146
UA - Ucraina 949
DE - Germania 406
IT - Italia 363
PL - Polonia 363
HK - Hong Kong 310
FI - Finlandia 260
SG - Singapore 187
GB - Regno Unito 184
IE - Irlanda 172
FR - Francia 86
IN - India 82
BE - Belgio 26
SE - Svezia 24
CA - Canada 21
CZ - Repubblica Ceca 18
IR - Iran 16
VN - Vietnam 14
RU - Federazione Russa 13
TR - Turchia 13
AU - Australia 11
NL - Olanda 10
EU - Europa 7
JP - Giappone 7
CL - Cile 5
AT - Austria 4
GR - Grecia 4
BR - Brasile 3
AM - Armenia 2
EE - Estonia 2
ES - Italia 2
IL - Israele 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 13.426
Città #
Fairfield 1.407
Woodbridge 1.143
Houston 757
Jacksonville 696
Ashburn 650
Seattle 567
Ann Arbor 556
Cambridge 527
Wilmington 476
Warsaw 363
Chandler 356
Princeton 310
Hong Kong 305
Nanjing 227
Beijing 208
New York 191
Dublin 171
Helsinki 148
Brescia 129
Dearborn 106
Singapore 102
Nanchang 95
Shenyang 76
San Diego 72
Des Moines 71
Hebei 68
Jinan 64
Changsha 63
Shanghai 56
Milan 47
Tianjin 46
Lancaster 35
Jiaxing 34
London 31
Verona 27
Brussels 26
Hangzhou 26
Ningbo 26
San Francisco 26
Haikou 22
San Mateo 22
Taizhou 22
Boardman 21
Zhengzhou 20
Kunming 19
Kilburn 16
Toronto 16
Brno 15
Lanzhou 15
Washington 14
Ardabil 12
Dong Ket 12
Leawood 12
Pune 12
Salerno 12
Guangzhou 11
Norwalk 11
Taiyuan 10
Hounslow 9
Changchun 8
Falls Church 8
Kocaeli 8
Los Angeles 8
Augusta 7
Melbourne 7
Orange 7
Chicago 6
Roccafranca 6
Tokyo 6
Vignate 6
Rome 5
St Louis 5
Wuhan 5
Calvisano 4
Gunzenhausen 4
Islington 4
Lappeenranta 4
Monmouth Junction 4
New Bedfont 4
Phoenix 4
Redwood City 4
West Jordan 4
Amsterdam 3
Berlin 3
Chiswick 3
Hefei 3
Naples 3
Treviglio 3
Vienna 3
Acton 2
Almere Stad 2
Atlanta 2
Bergenfield 2
Canberra 2
Central 2
Deiva Marina 2
Ferrara 2
Fort Worth 2
Fremont 2
Fulda 2
Totale 10.758
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 275
TREM2 sustains microglial expansion during aging and response to demyelination 217
Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration. 194
Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt 165
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 155
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 153
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 144
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 144
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 143
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 141
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 141
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 140
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 138
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration 138
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 137
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 133
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay 127
Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification 124
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 121
MiR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression 119
Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infection 118
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 117
Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development 113
CCRL2 regulates M1/M2 polarization during EAE recovery phase 113
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 111
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 111
Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome 110
Glioblastoma models driven by different mutations converge to the proneural subtype 109
A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice 108
Beta-Galactosylceramidase deficiency: neurovascular implications 108
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 107
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 107
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients 106
Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene 105
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines 104
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 104
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3 103
Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency 103
Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function 102
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 102
Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis. 101
Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis 101
Leucine-rich repeat containing 8A (LRRC8A)-dependent volume-regulated anion channel activity is dispensable for T-cell development and function 101
Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells 100
Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption 100
Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome 99
Critical role for prokineticin 2 in CNS autoimmunity 99
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome 98
Cytokine Therapy in Immune-mediated Demyelinating Diseases of the Central Nervous System: a Novel Gene Therapy Approach 97
Defect of regulatory T cells in patients with Omenn syndrome 97
Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency 97
High doses of cobalt induce optic and auditory neuropathy 97
Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1 96
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas 96
Thymus Transplantation for Complete Digeorge Syndrome: European Experience 96
The Different Faces of Angiogenesis in Neuroblastoma 95
The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation 94
Cytokines and Immunity in Multiple Sclerosis: the Dual Signal Hypothesis 94
Caveolins in rhabdomyosarcoma 94
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models 94
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 93
18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 93
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 92
Sustained Activation of mTOR Pathway in Embryonic Neural Stem Cells Leads to Development of Tuberous Sclerosis Complex-associated Lesions 92
Thymus microenvironment in human primary immunodeficiency diseases 91
Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment 91
Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review 91
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 91
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 90
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 89
Dexamethasone inhibits the anti-tumor effect of interleukin-4 on rat experimental gliomas 89
Human Peripheral Lymphoid Tissues Contain Autoimmune Regulator-Expressing Dendritic Cells 89
Hypomorphic Rag mutations can cause destructive midline granulomatous disease 88
Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein 88
In Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott-Aldrich Syndrome Protein-Deficient B Cells 88
Drug inducible transgene expression in brain using a Herpes Simplex virus vector 87
Homozygous DNA Ligase IV R278H Mutation in Mice Leads to Leaky Scid and Represents A Model For Human LIG4 Syndrome 87
Replication-defective Herpes Simplex virus vectors for gene transfer in vivo 86
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma 86
Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome 86
Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement 86
Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects 86
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 85
Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome 85
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit(W-sh/W-sh) mice. 85
NK cells recognize and kill human glioblastoma cells with stem cell-like properties 84
The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses 84
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1 83
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells 82
Anti-CD3{epsilon} mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications 81
Rag defects and thymic stroma: lessons from animal models 81
High-Definition 3-Dimensional Exoscope for 5-ALA Glioma Surgery: 3-Dimensional Operative Video 81
Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice 80
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 80
Schwann cells in neuroblastoma express erythropoietin 78
Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors 78
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 75
ZAP70 deficiency in humans is associated with abnormalities of thymic stromal cells: implications for T cell tolerance 74
Totale 10.649
Categoria #
all - tutte 64.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.835 479 110 136 480 241 431 351 410 274 567 148 208
2020/20212.729 48 268 210 359 111 300 124 279 320 279 291 140
2021/20221.280 91 254 24 60 21 58 80 97 56 142 109 288
2022/20231.113 173 28 31 55 117 300 1 111 171 18 56 52
2023/20241.404 92 31 142 85 61 265 67 68 328 37 24 204
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 13.716